Fay Law Group, P.A.
Free Initial Consultations Phone Answered 24 Hours A Day
800-522-2715
202-644-8854
202-644-8854

Johnson & Johnson sued over prescription medication Xarelto

As many residents of Washington, D.C., may already be aware, 2016 was not the best year for the company Johnson & Johnson, and, with thousands of both state and federal lawsuits against them already, 2017 isn't shaping up to be much better. This newest round of pharmaceutical litigation involves the prescription medication Xarelto. The lawsuits all involve individuals who experienced severe internal bleeding after taking the anticoagulant.

Xarelto was developed to be an alternative to the drug warfarin, brand name Coumadin. A prescription medication used to thin the blood, Warfarin has been around for nearly 70 years. Its blood-thinning properties are easily reversed with a dose of vitamin K, but this means that patients cannot eat any foods containing that vitamin while using the medication.

Because of this admittedly minor but still bothersome detail, drug manufacturers started attempting to develop alternative blood thinning medications, which the FDA began approving in 2010. While these alternative anticoagulants were easy to take, they proved problematic when it came time to stop the bleeding, such as in cases of emergencies. Minor knocks to the head led to a number of fatalities, as did uncontrollable intestinal bleeding.

In fact, 2015 studies showed that Xarelto has a rate of bleeding much higher than Coumadin or any of the other prescription medication competitors. Despite this research, Johnson & Johnson allegedly continued to aggressively market the drug, and the company stands accused of downplaying the high risks of unstoppable bleeding. They currently face more than 15,000 lawsuits across the nation against the company itself and several of its subsidiaries, including Bayer Healthcare and Janssen Pharmaceutical. Washington, D.C., residents deserve to know of the risks involved with this potentially life-threatening medication, and anyone who has been adversely affected by this or any other dangerous prescription medications may wish to consult an attorney.

Source: dailyhornet.com, "Xarelto Trials Begin April 24 Unless Lawyers Reach Settlement ??? Daily Hornet", Elizabeth Bradley, April 5, 2017

No Comments

Leave a comment
Comment Information
Our Promise To You No matter what your case involves, you can depend on Fay Law Group for honest advice, careful attention to detail, and individualized client service. Contact us today to schedule your free initial consultation.
Proud Sponsors We here at Fay Law Group, P.A., continue a tradition of military support established more than 40 years ago.
attorney photo

Washington Office
777 Sixth Street, N.W.
Suite 410
Washington, DC 20001

Map & Directions

Rockville Office
206 North Adams
Rockville, MD 20850

Map & Directions

Silver Spring Office
2048 Merrifield Drive
Silver Spring, MD 20906

Map & Directions

Frederick Office
235 W. Patrick Street
Frederick, MD 21701

Map & Directions